Biological risk assessment and management is our tool to foster the positive impact of the advancement of bioscience and biotechnology for society.

S1 Adapted solutions for
biorisk management

S2 Evaluation of new
techniques and
environmental risk
assessment

S3 Applicable misuse
prevention and
biosecurity

S4 Promotion of global
biosafety and biosecurity

S5 Mentoring of biosafety
and biosecurity
professionals

S6 Public communication
and open-space
biosafety

Us and our partnering network

During our 20 years of business, we have consequently and consistently built and maintained our partnership with experts and partnering networks internationally.

Highlights of the World Vaccine Congress Europe 19-21 October 2021 in Barcelona

Oktober 26 2021
Thanks to the tremendous efforts of Terrapinn UK the 2021 World Vaccine Congress Europe could take place on site. Highlights related to the COVID-19 pandemic and other vaccines are summarized below.

Gene technology for sustainable development

Juli 12 2021
Gene technology for sustainable development: a genetically modified Saccharomyces cerevisiae to produce ethanol from toxified lignocellulosic feedstocks

Nobel Prize Summit OUR PLANET OUR FUTURE Urgent Call for Action

Mai 21 2021
The 2021 Nobel Prize Summit of April 2021, has resulted in an Urgent Call for Action concluding that global sustainability offers the only viable path forward in the Anthropocene epoch.
Go to Blog
«Jenal & Partners have supported us for an urgent project with their professional expertise regarding environmental risk assessments, and this on very short notice. Their concise and efficient work allowed us to stay on track with our programme. The friendly communication style and a profound understanding of the field made the project successful and the collaboration highly enjoyable.»
Florence Salmon, former Portfolio Head Regulatory Affairs CMC, Cell and Gene Therapies at Novartis, Switzerland
«Zusammenarbeit: Dui pellentesque a quis semper nunc accumsan risus gravida adipiscing. Pellentesque ac egestas venenatis massa lobortis nibh interdum.»
Viji Vijayan, MD, Associate Professor, Duke-National University of Singapore Medical School, American Biological Safety Association